Page 56 - Sohini Das

Cough syrup makers see healthy future, say controversies won't dent demand

Pharma industry insiders claimed that most contamination-related problems arise due to solvents

We won't make an acquisition just because we have to: Piramal Pharma chief

In a Q&A, Nandini Piramal, chairperson of the firm, says the company currently sees great scope in expanding and organically growing the OTC business, and wants to build more consumer focused brands

New Covid strains, seasonal ailments may spike hospitalisation in winter

13 XBB variants detected in Maharashtra are all under home-isolation; the strain spreads rapidly and is said to be behind the recent spike in Singapore

Winter is coming: New Covid-19 variants prompt alert for illness season

Health minister Mansukh Mandaviya holds review meeting as experts call for continued vigil

Govt reviews Covid situation as Omicron subvariant BQ.1 detected in Pune

The BQ.1 is a mutation of BA.5, which is behind 60% Covid cases in the US

India now has 20,000 tonnes per day Oxygen capacity. 90% of it lying idle

There are 1,242 liquid medical oxygen tanks in hospitals across India with a capacity of 15,622 tonnes. This is a 104 % rise in the number of tanks and a 131% increase in storage capacity

Several states initiate action over contaminated cough syrup controversy

According to the media reports, Karnataka has directed all drugmakers to test samples of glycerine and propylene glycol and submit a report within seven days.

Manipal Health may launch IPO after deal to buy AMRI Hospitals

Manipal Health is India's second-largest hospital chain, is estimated to have 8,700 hospital beds

Drug regulator halts production at Maiden Pharma's Sonipat unit

Centre forms panel to analyse causal relation between deaths and cough syrups

Haryana stops production at plant making cough syrups flagged by WHO

12 violations found at Maiden Pharmaceuticals' Sonipat facility, says state health minister

Temporary Covid-19 centres getting dismantled amid signs pandemic is ending

About 92% of cases in India are said to be having mild disease. In only 5.8% of cases oxygen therapy is required, intensive care in only 1.7% cases

Preliminary report suggests lapse in manufacturing process at Maiden Pharma

The firm has been in news for supplying contaminated cough syrups to Gambia, which is linked to the deaths of 66 children due to the presence of contaminants

India's first Covid cure Vincov-19 completes second phase clinical trial

These highly purified antibody fragments have a high neutralising capacityagainst the Sars-CoV-2 virus

Indian Immunologicals to double foot and mouth disease vaccine capacity

To Invest Rs 700 crore in Hyderabad for new animal vaccine facility

Maiden Pharma may lose import-export code over cough syrup deaths in Gambia

Pharmexcil suspends membership; may recommend DGFT to withdraw Import-Export Code

Advisory board urges ban on codeine cough drugs, regulator to take call

Codeine formulations constitute 8% of cough and cold market; pharma industry asks govt not to ban a 'safe' medicine for abuse by some

Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources

Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia

Haryana drug firm under WHO scanner for supplying contaminated drugs

Maiden Pharma has manufactured and exported the products only to Gambia so far

Over 100 million Covid-19 vaccine doses wasted in India by September-end

Covid-19 vaccine makers have no plans to seek further shelf life extensions

End of the pandemic in sight, but is it time to let down the guard?

While the world is moving away from the most basic Covid-19 protocols, some experts say it is too early to declare that the pandemic is over